|
|
Volumn 78, Issue 9 A, 1996, Pages 13-18
|
|
Re-examining the clinical safety and roles of calcium antagonists in cardiovascular medicine.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
VERAPAMIL;
CARDIOVASCULAR DISEASE;
CORONARY BLOOD VESSEL;
DRUG EFFECT;
HEART ARRHYTHMIA;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HEART VENTRICLE FUNCTION;
HUMAN;
PHYSIOLOGY;
REVIEW;
ANTI-ARRHYTHMIA AGENTS;
ARRHYTHMIA;
CALCIUM CHANNEL BLOCKERS;
CARDIOVASCULAR DISEASES;
CORONARY VESSELS;
DILTIAZEM;
HUMANS;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
VENTRICULAR DYSFUNCTION;
VERAPAMIL;
|
|
EID: 0030574221
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(96)00733-3 Document Type: Article |
|
Times cited : (9)
|
|
References (78)
|
